Viridian Therapeutics
VRDN
#5467
Rank
S$1.26 B
Marketcap
$15.53
Share price
-8.46%
Change (1 day)
-29.14%
Change (1 year)

Revenue for Viridian Therapeutics (VRDN)

Revenue in 2024 (TTM): S$0.4 Million

According to Viridian Therapeutics's latest financial reports the company's current revenue (TTM ) is S$0.4 Million. a decrease over the revenue in the year 2023 that were of S$0.41 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Viridian Therapeutics from 2013 to 2024

Annual revenue

Year Revenue Change
2024 S$0.41 M-1.01%
2023 S$0.41 M-82.54%
2022 S$2.37 M-40.7%
2021 S$4 M188.37%
2020 S$1.38 M-76.9%
2019 S$6.01 M-47.5%
2018 S$11.45 M113.98%
2017 S$5.35 M10.86%
2016 S$4.82 M34.47%
2015 S$3.59 M-37.09%
2014 S$5.7 M4.39%
2013 S$5.46 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA